Contact
Please use this form to send email to PR contact of this press release:
Onxeo announces allowance of U.S. patent for Livatag® in hepatocellular carcinoma
TO:
Please use this form to send email to PR contact of this press release:
Onxeo announces allowance of U.S. patent for Livatag® in hepatocellular carcinoma
TO: